menu search

Philips' device for inferior vena cava filter removal scores fda approval

The FDA has authorized the first laser-based device to remove IVC filters, developed by Koninklijke Philips NV (NYSE: PHG). Authorization was give...

December 22, 2021, 1:19 pm

Philips' device for inferior vena cava filter removal scores fda approval

The FDA has authorized the first laser-based device to remove IVC filters, developed by Koninklijke Philips NV (NYSE: PHG). Authorization was give...

December 22, 2021, 1:19 pm

Philips' device for inferior vena cava filter removal scores fda approval

The FDA has authorized the first laser-based device to remove IVC filters, developed by Koninklijke Philips NV (NYSE: PHG). Authorization was give...

December 22, 2021, 1:19 pm

Kazia therapeutics appoints us-based cfo to assist global market expansion

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has appointed Karen Krumeich as chief financial officer to focus on building and maintaining relationsh...

December 12, 2021, 6:48 pm

Kazia therapeutics appoints us-based cfo to assist global market expansion

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has appointed Karen Krumeich as chief financial officer to focus on building and maintaining relationsh...

December 12, 2021, 6:48 pm

Kazia therapeutics appoints us-based cfo to assist global market expansion

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has appointed Karen Krumeich as chief financial officer to focus on building and maintaining relationsh...

December 12, 2021, 6:48 pm

Archer materials develops sensing pathways to detect genetic information for biochip technology

Archer Materials Ltd (ASX:AXE, OTC:ARRXF) has advanced its biochip technology a step further toward commercialisation, developing the first biochemica...

November 30, 2021, 10:31 pm

Archer materials develops sensing pathways to detect genetic information for biochip technology

Archer Materials Ltd (ASX:AXE, OTC:ARRXF) has advanced its biochip technology a step further toward commercialisation, developing the first biochemica...

November 30, 2021, 10:31 pm

Archer materials develops sensing pathways to detect genetic information for biochip technology

Archer Materials Ltd (ASX:AXE, OTC:ARRXF) has advanced its biochip technology a step further toward commercialisation, developing the first biochemica...

November 30, 2021, 10:31 pm

Novartis' iptacopan meets primary endpoint goal in rare kidney disease trial

Novartis AG (NYSE: NVS) has announced Phase 2 trial data of iptacopan, a selective factor B inhibitor, in patients with C3 glomerulopathy (C3G). In C...

November 4, 2021, 1:45 pm

Novartis' iptacopan meets primary endpoint goal in rare kidney disease trial

Novartis AG (NYSE: NVS) has announced Phase 2 trial data of iptacopan, a selective factor B inhibitor, in patients with C3 glomerulopathy (C3G). In C...

November 4, 2021, 1:45 pm

Novartis' iptacopan meets primary endpoint goal in rare kidney disease trial

Novartis AG (NYSE: NVS) has announced Phase 2 trial data of iptacopan, a selective factor B inhibitor, in patients with C3 glomerulopathy (C3G). In C...

November 4, 2021, 1:45 pm

Pacira biosciences to acquire flexion therapeutics further expanding leadership position in non-opioid pain management

-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain <...

October 11, 2021, 7:00 am

Pacira biosciences to acquire flexion therapeutics further expanding leadership position in non-opioid pain management

-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain <...

October 11, 2021, 7:00 am

Pacira biosciences to acquire flexion therapeutics further expanding leadership position in non-opioid pain management

-- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain <...

October 11, 2021, 7:00 am

Why compass pathways stock dropped 12% in september

Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....

October 5, 2021, 6:29 pm

Why compass pathways stock dropped 12% in september

Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....

October 5, 2021, 6:29 pm

Why compass pathways stock dropped 12% in september

Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....

October 5, 2021, 6:29 pm

Why compass pathways stock dropped 12% in september

Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....

October 5, 2021, 6:29 pm

Why compass pathways stock dropped 12% in september

Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy....

October 5, 2021, 6:29 pm


Search within

Pages Search Results: